Children’s Hospital Colorado
2
30M
2
0.02
- Areas of investment
Summary
The main department of described Corporate Investor is located in the Aurora. The company was established in North America in United States.
The top activity for fund was in 2019. The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight RxRevu, RxRevu. We can highlight the next thriving fund investment areas, such as Analytics, Hospital.
The typical case for the fund is to invest in rounds with 7 participants. Despite the Childrenu2019s Hospital Colorado, startups are often financed by UnityPoint Health, UVA Licensing & Ventures Group, UCHealth. The meaningful sponsors for the fund in investment in the same round are UnityPoint Health, UVA Licensing & Ventures Group, UCHealth. In the next rounds fund is usually obtained by UnityPoint Health, UVA Licensing & Ventures Group, UCHealth.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Rounds per year
- 0.02
- Investments by industry
- Health Care (2)
- Analytics (1)
- Information Technology (1)
- Hospital (1)
- Therapeutics (1) Show 2 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Q32 Bio | 27 May 2020 | Biotechnology, Health Care, Medical, Therapeutics | Early Stage Venture | 46M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.